Xenon Pharmaceuticals Inc... (XENE)
40.26
0.61 (1.54%)
At close: Jan 15, 2025, 12:54 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 148.64M | 57.24M | 175.69M | 45.01M | 24.75M | 67.75M | 20.49M | 17.09M | 58.65M | 72.03M | 37.95M | 60.16M |
| Short-Term Investments | 489.44M | 534.85M | 376.09M | 131.99M | 116.60M | 51.55M | 23.18M | 47.05M | n/a | 12.02M | 11.33M | n/a |
| Long-Term Investments | 292.79M | 128.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 7.40M | 7.75M | n/a | n/a | n/a | -105.00K | 230.00K | 408.00K | 1.09M | n/a | 2.74M | -2.60M |
| Receivables | 874.00K | 986.00K | 2.77M | 1.82M | 813.00K | 151.00K | 438.00K | 200.00K | 315.00K | 215.00K | 440.00K | 392.00K |
| Inventory | n/a | -986.00K | -2.77M | -1.82M | n/a | n/a | 1.00 | 1.00 | -315.00K | 1.00 | 1.00 | n/a |
| Other Current Assets | 6.01M | 7.22M | 4.48M | 2.96M | 2.69M | 1.88M | 716.00K | 1.33M | 1.90M | 686.00K | 153.00K | 298.00K |
| Total Current Assets | 644.96M | 600.30M | 559.02M | 181.78M | 144.87M | 121.44M | 44.82M | 65.67M | 60.87M | 84.94M | 49.87M | 60.70M |
| Property-Plant & Equipment | 18.85M | 16.91M | 12.52M | 6.88M | 2.59M | 991.00K | 1.07M | 1.40M | 1.99M | 2.48M | 1.88M | 2.60M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 319.84M | 153.85M | 12.99M | 7.40M | 2.83M | 991.00K | 1.30M | 1.81M | 3.08M | 2.48M | 4.62M | 2.60M |
| Total Assets | 964.80M | 754.15M | 572.01M | 189.19M | 147.70M | 122.43M | 46.12M | 67.49M | 63.95M | 87.42M | 54.49M | 63.30M |
| Account Payables | 8.60M | 8.49M | 3.82M | 3.04M | 2.47M | 665.00K | 1.25M | 1.46M | 1.09M | 553.00K | 391.00K | 821.00K |
| Deferred Revenue | n/a | n/a | 9.29M | 3.64M | 29.74M | -15.01M | n/a | n/a | 157.00K | 11.62M | 15.92M | 17.02M |
| Short-Term Debt | 1.30M | 488.00K | 605.00K | 265.00K | 4.82M | n/a | 700.00K | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 17.38M | 13.72M | 9.89M | 7.83M | 6.34M | 3.45M | 2.13M | 2.05M | 1.54M | 2.11M | 1.89M | 1.36M |
| Total Current Liabilities | 27.27M | 22.70M | 14.32M | 14.78M | 43.38M | 4.12M | 4.08M | 3.52M | 2.78M | 14.29M | 18.20M | 19.20M |
| Long-Term Debt | 9.60M | 9.95M | 7.65M | 3.05M | 11.63M | 15.01M | 6.10M | n/a | n/a | n/a | n/a | 1.67M |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 133.00K | 196.00K | 282.00K | 184.00K |
| Total Long-Term Liabilities | 9.60M | 9.95M | 7.65M | 3.05M | 12.34M | 15.01M | 6.10M | 70.00K | 133.00K | 353.00K | 12.17M | 31.49M |
| Total Liabilities | 36.88M | 32.65M | 21.97M | 17.83M | 55.72M | 19.13M | 10.19M | 3.59M | 2.92M | 14.64M | 30.37M | 50.68M |
| Total Debt | 10.90M | 10.44M | 8.26M | 3.31M | 16.45M | 15.01M | 6.80M | n/a | n/a | n/a | n/a | 1.67M |
| Common Stock | 1.44B | 1.07B | 783.17M | 397.75M | 294.24M | 265.92M | 173.84M | 173.25M | 148.63M | 147.16M | 6.15M | 6.01M |
| Retained Earnings | -665.14M | -482.75M | -357.37M | -278.49M | -249.66M | -207.88M | -173.39M | -142.68M | -119.69M | -103.73M | -116.75M | -128.78M |
| Comprehensive Income | -77.00K | -3.00M | -990.00K | -990.00K | -990.00K | -990.00K | -990.00K | -990.00K | -990.00K | -990.00K | 2.51M | 3.75M |
| Shareholders Equity | 927.92M | 721.50M | 550.03M | 171.35M | 91.98M | 103.30M | 35.93M | 63.90M | 61.03M | 72.78M | 24.12M | 12.62M |
| Total Investments | 782.23M | 663.53M | 376.09M | 131.99M | 116.60M | 51.55M | 23.18M | 47.05M | n/a | 12.02M | 11.33M | n/a |